Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Wu, Muzhou ^a   Nissen, Jillian C ^a   Chen, Emily I ^a   Tsirka, Stella E ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUFTSIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; FEMALE; IMMUNOREGULATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; CULTURE MEDIA, CONDITIONED; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROGLIA; PHENOTYPE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TUFTSIN;

ANIMALIA; MUS;

EID: 84859841514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034933     Document Type: Article

References (66)

1. Swanborg RH, (1995) Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 77: 4-13.
2. Raivich G, Banati R, (2004) Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev 46: 261-281.
3. Rott O, Fleischer B, Cash E, (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24: 1434-1440.
4. Stevens DB, Gould KE, Swanborg RH, (1994) Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J Neuroimmunol 51: 77-83.
5. Kreutzberg GW, (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19: 312-318.
6. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK, (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149: 2736-2741.
7. Rott O, Fleischer B, Cash E, (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. European Journal of Immunology 24: 1434-1440.
8. Mosmann TR, Coffman RL, (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
9. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
10. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8: 500-508.
11. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK, (2006) Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 203: 2785-2791.
12. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957.
13. Olivares-Villagomez D, Wang Y, Lafaille JJ, (1998) Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188: 1883-1894.
14. Kohm AP, Carpentier PA, Anger HA, Miller SD, (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169: 4712-4716.
15. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S, (2006) Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 12: 518-525.
16. McGeachy MJ, Stephens LA, Anderton SM, (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175: 3025-3032.
17. Nishioka K, Sato PS, Constantopoulos A, Najjar VA, (1973) The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties. Biochim Biophys Acta 310: 230-237.
18. Siemion IZ, Kluczyk A, (1999) Tuftsin: on the 30-year anniversary of Victor Najjar's discovery. Peptides 20: 645-674.
19. Herman ZS, Stachura Z, Opielka L, Siemion IZ, Nawrocka E, (1981) Tuftsin and D-Arg3-tuftsin possess analgesic action. Experientia 37: 76-77.
20. Thanos S, Mey J, Wild M, (1993) Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 13: 455-466.
21. Bhasin M, Wu M, Tsirka SE, (2007) Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol 8: 10.
22. Paul C, Peers SH, Woodhouse LE, Thornback JR, Goodbody AE, et al. (2000) The detection and quantitation of inflammation in the central nervous system during experimental allergic encephalomyelitis using the radiopharmaceutical 99mTc-RP128. J Neurosci Methods 98: 83-90.
23. Lu W, Bhasin M, Tsirka SE, (2002) Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis. J Neurosci 22: 10781-10789.
24. Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, et al. (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75: 77-88.
25. Hjelmstrom P, Juedes AE, Fjell J, Ruddle NH, (1998) B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 161: 4480-4483.
26. Wu M, Tsirka SE, (2009) Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis. Glia.
27. Funderburg N, Luciano A, Jiang W, Rodriguez B, Sieg S, et al. (2008) Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 3: e1915.
28. Nieuwenhuis E, Neurath M, Corazza N, Iijima H, Trgovcich J, et al. (2002) Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci U S A 99: 16951-16956.
29. Rogove A, Tsirka S, (1998) Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 8: 19-25.
30. Siao CJ, Tsirka SE, (2002) Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 22: 3352-3358.
31. Yao Y, Tsirka SE, (2010) The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency. J Biol Chem 285: 31509-31516.
32. Zhai H, Heppner FL, Tsirka SE, (2011) Microglia/macrophages promote glioma progression. Glia 59: 472-485.
33. Siddiq MM, Tsirka SE, (2004) Modulation of zinc toxicity by tissue plasminogen activator. Mol Cell Neurosci 25: 162-171.
34. Bukhari N, Torres L, Robinson JK, Tsirka SE, (2011) Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system. J Neurosci 31: 14931-14943.
35. Kersey P, Duarte J, Williams A, Karavidopoulou Y, Birney E, et al. (2004) The International Protein Index: An integrated database for proteomics experiments. Proteomics 4: 1985-1988.
36. Elias J, Gygi S, (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nature Meth 4: 207-214.
37. Eng J, McCormack A, Yates Jr, (1994) An Approach to Correlate Tandem Mass Spectral Data of Peptides with Amino Acid Sequences in a Protein Database. J Am Soc Mass Spectrom 5: 976-989.
38. Liu H, Sadygov R, Yates Jr, (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76: 4193-4201.
39. Carvalho P, Hewel J, Barbosa V, Yates Jr, (2008) Identifying differences in protein expression levels by spectral counting and feature selection. Genet Mol Res 7: 342-356.
40. Pitt D, Werner P, Raine C, (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nature Med 6: 67-70.
41. Smith T, Groom A, Zhu B, Turski L, (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6: 62-66.
42. Gordon S, Martinez F, (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32.
43. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P, (2009) Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 210: 3-12.
44. Kigerl K, Gensel J, Ankeny D, Alexander J, Donnelly D, et al. (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci pp. 43.
45. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, et al. (2010) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of Multiple Sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler.
46. Lai A, Todd K, (2008) Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 56: 259-270.
47. von Wronski MA, Raju N, Pillai R, Bogdan NJ, Marinelli ER, et al. (2006) Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J Biol Chem 281: 5702-5710.
48. Crawford H, Dempsey P, Brown G, Adam L, Moss M, (2009) ADAM10 as a therapeutic target for cancer and inflammation. Curr Pharm Des 15: 2288-2299.
49. Ye B, Cattoretti G, Shen Q, Zhang J, Hawe N, et al. (1997) The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16: 161-170.
50. Wei J, Duramad O, Perng O, Reiner S, Liu Y, et al. (2007) Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 104: 18169-18174.
51. Lloyd C, Delaney T, Nguyen T, Tian J, Martinez A, et al. (2000) CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 191: 265-274.
52. Bonecchi R, Bianchi G, Bordignon P, D'Ambrosio D, Lang R, et al. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187: 129-134.
53. Ferber I, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, et al. (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156: 5-7.
54. Jee Y, Kim G, Tanuma N, Matsumoto Y, (2001) STAT expression and localization in the central nervous system during autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol 114: 40-47.
55. Benveniste E, (1997) Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75: 165-173.
56. Diemel LT, Copelman CA, Cuzner ML, (1998) Macrophages in CNS remyelination: friend or foe? Neurochemical Research 23: 341-347.
57. Fridkin M, Najjar VA, (1989) Tuftsin: its chemistry, biology, and clinical potential. Crit Rev Biochem Mol Biol 24: 1-40.
58. Veeravalli KK, Dasari VR, Tsung AJ, Dinh DH, Gujrati M, et al. (2009) Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury. Neurochem Res 34: 1183-1194.
59. Abe Y, Nakamura H, Yoshino O, Oya T, Kimura T, (2003) Decreased neural damage after spinal cord injury in tPA-deficient mice. J Neurotrauma 20: 43-57.
60. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, et al. (2012) Identification of a microglia phenotype supportive of remyelination. Glia 60: 306-321.
61. Rabchevsky AG, Streit WJ, (1998) Role of microglia in postinjury repair and regeneration of the CNS. Mental Retardation and Developmental Disabilities Research Reviews 4: 187-192.
62. Stanislaus R, Gilg AG, Singh AK, Singh I, (2005) N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats. J Autoimmune Dis 2: 4.
63. Kim S, Ock J, Kim A, Lee H, Cho J-Y, et al. (2007) Neurotoxicity of microglial cathepsin D revealed by secretome analysis. J Neurochem 103: 2640-2650.
64. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, et al. (2002) A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 3: 477-482.
65. Gavazzi I, (2001) Semaphorin-neuropilin-1 interactions in plasticity and regeneration of adult neurons. Cell Tissue Res 305: 275-284.
66. Wang L, Zeng H, Wang P, Soker S, Mukhopadhyay D, (2003) Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem 278: 48848-48860.